Brief: Avadel Receives Unsolicited Proposal From Lundbeck
14/11/2025 10:51
Nov 14 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O: AVADEL RECEIVES UNSOLICITED PROPOSAL FROM LUNDBECK AVADEL PHARMACEUTICALS PLC - RECEIVES UNSOLICITED PROPOSAL FROM LUNDBECK FOR $23 PER SHARE AVADEL PHARMACEUTICALS PLC - PROPOSAL INCLUDES $21 CASH PER SHARE PLUS CONTINGENT VALUE RIGHTS Source text: ID:nGNX8YHqQr Further company coverage: AVDL.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet